Karmanos Cancer Institute/BMT
Detroit, Michigan, United States
Cancer treatment center in Detroit, Michigan
4100 John R St, Detroit, MI 48201
123 Beds
About Karmanos Cancer Institute/BMT
The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, is the largest cancer research and provider network in Michigan and has 16 treatment locations. It is one of 51 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States.
There are 123 beds in Karmanos Cancer Institute/BMT.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Karmanos Cancer Institute/BMT
During the past decade, Karmanos Cancer Institute/BMT conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on
average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Karmanos Cancer Institute/BMT"
#1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "National Marrow Donor Program" with 5 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Karmanos Cancer Institute/BMT
According to Clinical.Site data, the most researched conditions in "Karmanos Cancer Institute/BMT" are
"Follicular Lymphoma" (2 trials), "Multiple Myeloma" (2 trials), "Acute Leukemia" (1 trials), "Acute Lymphocytic Leukemia" (1 trials) and "Acute Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "Karmanos Cancer Institute/BMT" in a lesser frequency.
Clinical Trials Intervention Types at Karmanos Cancer Institute/BMT
Most popular intervention types in "Karmanos Cancer Institute/BMT" are "Drug" (5 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lenalidomide" (2 trials), "Allogeneic Hematopoietic Cell Transplant" (1 trials), "Allogeneic transplant" (1 trials), "Autologous transplant" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Karmanos Cancer Institute/BMT
The vast majority of trials in "Karmanos Cancer Institute/BMT" are
7 trials for "All" genders.
Clinical Trials Status at Karmanos Cancer Institute/BMT
Currently, there are NaN active trials in "Karmanos Cancer Institute/BMT".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Karmanos Cancer Institute/BMT,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Karmanos Cancer Institute/BMT, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".